Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer-Reference-Cited by-同舟云学术

Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer

Published:2016-02-19 Issue:3 Volume:107 Page:315-319
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sekine Ikuo¹,Sumi Minako²,Satouchi Miyako³,Tsujino Kayoko⁴,Nishio Makoto⁵,Kozuka Takuyo⁶,Niho Seiji⁷,Nihei Keiji⁸,Yamamoto Nobuyuki⁹,Harada Hideyuki¹⁰,Ishikura Satoshi¹¹,Tamura Tomohide¹

Affiliation:

1. Division of Internal Medicine and Thoracic Oncology National Cancer Center Hospital Tokyo Japan

2. Division of Radiation Oncology National Cancer Center Hospital TokyoJapan

3. Department of Thoracic Oncology Hyogo Cancer Center Akashi Japan

4. Department of Radiation Oncology Hyogo Cancer Center AkashiJapan

5. Thoracic Oncology CenterCancer Institute Hospital Japanese Foundation for Cancer Research Tokyo Japan

6. Department of Radiation Oncology Cancer Institute Hospital Japanese Foundation for Cancer Research TokyoJapan

7. Division of Thoracic Oncology National Cancer Center Hospital East Kashiwa Japan

8. Division of Radiation Oncology National Cancer Center Hospital East KashiwaJapan

9. Thoracic Oncology Division Shizuoka Cancer Center Shizuoka Japan

10. Radiotherapy Division Shizuoka Cancer Center ShizuokaJapan

11. Department of Radiology Koshigaya Municipal Hospital Koshigaya Japan

Funder

National Cancer Center Research and Development Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12875

Reference12 articles.

1. Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality Therapy

2. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104

3. Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

4. Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

5. Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study;Thoracic Cancer;2022-07-08

2. Magnetic particle targeting for diagnosis and therapy of lung cancers;Journal of Controlled Release;2020-12

3. Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-stage Small-cell Lung Cancer;In Vivo;2020

4. Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer;Cancer Chemotherapy and Pharmacology;2019-09-05

5. Synergism of ursolic acid and cisplatin promotes apoptosis and enhances growth inhibition of cervical cancer cells via suppressing NF-κB p65;Oncotarget;2017-10-30